New approach to managing warfarin patients improves care, cuts costs

January 10, 2017, Boston University Medical Center

New performance measures have been developed for patients on warfarin that may save lives and money.

Warfarin is a commonly prescribed anticoagulant (blood thinner) used by millions of Americans to treat or prevent blood clots and/or strokes. Warfarin management can be measured by the proportion of time patients spend in the therapeutic range—the range in which they are protected from and not at excessive risk of bleeding.

Previous research has shown that hospitals and physician offices vary in terms of how skillfully they manage their patients on this drug. Researchers from Boston University School of Medicine (BUSM) have now developed several performance measures intended to help hospitals and clinicians improve the management of warfarin in their patients. These findings appear in the Annals of Pharmacotherapy.

Patients on warfarin in the eight medical centers in the VA's New England region were compared to receiving warfarin in other parts of the country. "Patients who used these measures did better clinically than those in the control group," explained corresponding author Adam Rose, MD, associate professor of medicine at BUSM.

According to the researchers while previous studies have intervened to improve warfarin management at a single site or practice, this is the first such study to improve care across an entire health network.

"This study serves as a model for how other sites and health networks could feasibly approach improving the management of warfarin in their systems. If all anticoagulation clinics in the VA were to achieve this level of improvement, it would prevent 48 strokes and 68 major bleeding events each year, with a savings to the VA system of more than $4 million annually," he added.

Rose believes that if a similar approach were adopted by other large health systems, there could also be improvement of patient outcomes and savings due to averted adverse events. "Insufficient attention has been given in the past to how we can improve the of ; this study demonstrates that a relatively simple approach can have a large impact."

Explore further: Medication adherence a problem in atrial fibrillation patients

Related Stories

Medication adherence a problem in atrial fibrillation patients

January 4, 2017
For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of treatment is stroke prevention.

Atrial fibrillation patients are at increased risk of dementia, regardless of anticoagulation use

November 15, 2016
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial ...

Physician-perceived frailty tied to warfarin discontinuation

August 17, 2016
(HealthDay)—Physician-perceived frailty and low life expectancy are the main reasons for warfarin discontinuation in elderly patients, according to a study published online July 29 in the Journal of Thrombosis and Haemostasis.

PPI cuts risk of warfarin-related upper GI bleeding

December 23, 2016
(HealthDay)—For patients beginning warfarin therapy, proton pump inhibitor (PPI) co-therapy is associated with reduced risk of upper gastrointestinal bleeding, according to a study published in the December issue of Gastroenterology.

Zydus recalls single lot of blood thinner warfarin

June 12, 2013
Zydus Pharmaceuticals is recalling a single lot of the drug warfarin after receiving a complaint that some of the tablets are too large.

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.